All the 28 Bacteroides fragilis strains investigated were susceptible to sulfamethoxazole (minimal inhibitory concentration < 16 Ag/ml) and resistant to trimethoprim (TMP; minimal inhibitory concentration > 4 ,ug/ml). Synergism between sulfamethoxazole and TMP was present in all strains at a ratio of 1:1. The few clostridia investigated proved more resistant to both compounds. Dihydrofolate reductases from B. fragilis, C. perfringens, and some other anaerobic species were isolated. Inhibition profiles with six structurally different inhibitors revealed major differences in all enzymes. For 50% inhibition, the enzyme from B. fragilis and all clostridia required concentrations of TMP which were between several hundredfold and 1,000-fold higher than those required for the enzyme of Escherichia coli, whereas the enzyme from Propionibacterium acnes only needed a threefold higher concentration. In vitro activities of TMP were seen to correspond to the activity at the enzymatic level in B. fragilis and P. acnes, but corresponded to a much lesser extent to the activity at the enzymatic level in clostridia, where a poor penetration is assumed to be involved. Dihydrofolate reductase inhibitors other than TMP were found to be as active as TMP both at the enzyme and in vitro. In B. fragilis, higher concentrations of exogenous thymidine were required for increasing the minimal inhibitory concentration of TMP than in E. coli and probably also in C. perfringens.
known to be crucial factors in determining the sensitivity of anaerobes against TMP and sulfonamides (14, 19) . The present study was undertaken to elucidate the basis of the frequent resistance to TMP in anaerobes, mainly Bacteroides. Some of the results have been presented recently (17) .
MATERIALS AND METHODS
Strains. The strains used included 28 B. fragilis, 1 Bacteroides species, 3 Clostridium perfringens, 1 C. septicum, 1 C. tetanomorphum, 1 C. chauvoei, and 1 Propionibacterium acnes. Some of the strains were kindly provided by J. Wust (University of Zurich). They were maintained on agar plates on diagnostic sensitivity test (DST) agar (Oxoid Ltd., London) containing 7% human blood, in anaerobic jars (Baltimore Biological Laboratory [BBL] , Cockeysville, Md.) at room temperature.
Media. The minimal inhibitory concentration (MIC) determinations were performed on DST agar supplemented with hemin chloride (5 lAg/ml) and menadione (0.5 Ag/ml). The concentration of thymidine in this medium is below the level needed to antagonize the action of antifolate compounds (16) . In some cases, other media were used, as indicated below.
MIC determinations. The agar disk method described by Linzenmeier and Neussel (12) for susceptibility testing of aerobic bacteria was modified for anaerobes. Stock solutions of TMP and sulfamethoxazole (SMZ) were appropriately diluted in distilled water. The compounds were incorporated into the medium by adding 13.5 ml of melted DST agar (supplemented) to 1.5 mnl of diluted solution of the compound in Folin tubes. The contents of the tubes were poured into 9-cm petri dishes and allowed to solidify.
From the medium prepared in this way, agar disks with a surface of 0.8 cm2 were punched out and transferred to empty petri dishes, assembling a series of twofold dilution steps of the antibacterial compounds in the same dish. per min if a molar absorption coefficient of e = 12,300 is assumed for the reaction (10) . Determination of the 50% inhibitory concentrations (15os) occurred by titration with four to six inhibitor concentrations. Double determinations were carried out as far as possible. A statistical comparison of the inhibition profiles obtained for these strains with six structurally different inhibitors was carried out essentially as described (18) .
Miscellaneous. Dihydrofolate was prepared from folate as described by Blakley (3) . Aminopterin was obtained from Serva (Heidelberg, West Germany), triamterene was from Lederle (Pearl River, N.Y.), reduced nicotinamide adenine dinucleotide phosphate was obtained from Boehringer (Mannheim, West Germany), 2,4-diamino-6,7-diisopropylpteridine was obtained from Calbiochem (Los Angeles, Calif.), and 2,4-diamino-6,7-dimethylpteridine was obtained from Merck-Schuchardt (Munich, West Germany).
RESULTS
In vitro susceptibility to SMZ and TMP. The activity of TMP, alone and combined with SMZ, was investigated in 28 B. fragilis strains and 2 C. perfringens strains by the agar disk technique with supplemented DST agar as growth medium. All B. fragilis strains were susceptible to SMZ, exhibiting MICs of 1 to 16 ,ig/ml (mostly 2 to 8 ,ug/ml). The MIC for TMP was in the range of 4 to 16 ,ug/ml. The two C. perfringens strains were highly resistant to both compounds, the MIC being >128 for SMZ and >32 for TMP. Synergism between the two compou;ids was found to be present in B. fragilis, being generally more pronounced with the ratio of 1:1 than with the usual 10:1 or 20:1 for SMZ/TMP. This means that a higher level of TMP is required for optimal potentiation than in many common bacteria, reflecting its lower activity. Fractional inhibitory concentration indexes of 0.19 to 0.63 were observed with the 1:1 ratio.
Sensitivity to TMP of some DHFRs from anaerobes. Inhibition profiles of DHFRs isolated from several strains were recorded with the use of six structurally different inhibitors ( Table 1 ). The figures for E. coli B, S. aureus Schoch and the rat liver enzyme (as a eucaryotic enzyme) were included for comparison. The statistical analysis of the inhibition data revealed significant differences among all enzymes (a = 0.01). All enzymes from anaerobes are very sensitive to the structural analogs aminopterin and amethopterin, as are all DHFRs, with the exception of some R-factor-induced resistant ones (2) . However, all these enzymes were found to be considerably less sensitive to the diaminopyrimidine TMP than common pathogens, resulting in ten to several thousandfold higher I5os, in general 100-to 300-fold higher. C. tetanomor- In many of these TMP-insensitive strains, it is striking that pyrimethamine is as active or slightly more active than TMP, the I50 being in the range of that needed in the E. coli DHFR. The isopropylpteridine is also often as active as TMP in the reductases of anaerobes. Bacteroides sp. 31 and P. acnes 30 are exceptions, since they responded to TMP concentrations not too dissimilar to those needed in the E. coli DHFR.
Despite taking the precaution of adding 10 ,uM dihydrofolate during the purification procedure, which often stabilized the enzyme, DHFR from C. perfringens 11 proved unstable, with the result that not enough enzyme could be obtained to measure more than the TMP value.
In vitro activity of DHFR inhibitors other than TMP. To get some information on the ability of various structures to penetrate the cell of anaerobes, the in vitro activities of the structures used for probing the enzyme were also determined. This was done in 2 ml of Weilcotest broth. Those concentrations leading to L5o were determined. With few exceptions, all compounds are considerably less active against clostridia than against B. fragilis ( Table 2) . As with common bacteria, aminopterin is less active than TMP, being especially inactive in C. perfringens. The diisopropylpteridine derivative was found to be as active as TMP in vitro, with the exception of C. perfringens 11, against which it is much more active. Triamterene is generally less active than TMP, as is the dimethylpteridine, again with the exception of C. perfringens 11, which seems to be especially susceptible to 2,4-diamninopteridine structures. This strain was also relatively susceptible to aminopterin, as was C. septicum.
At the enzymatic level, pyrimethamine generally exhibited similar activity to that of TMP. This was found to be paralleled by the in vitro findings, not only for the strains listed in Table  2 , but also for five additional strains of B. fragilis and C. chauvoei which were tested.
Influence of the testing medium and thymidine on MICs. Although the results from the preceding sections suggest that the TMP insensitivity of Bacteroides and clostridia is due to the insensitive target enzyme, the influence of the testing medium on the MIC of TMP was studied in several anaerobes. DST agar and Wellcotest agar (Wellcome Research Laboratories, Beckenham, Kent, England), which are known to contain little thymidine, were compared to Schaedler medium (Oxoid) which, according to the much higher MIC of TMP obtained in E. coli (0.4 ,ug/ml with considerable trailing, in contrast to 0.04 Ag/ml in DST and Wellcotest agar), contains considerable thymidine (0.26 ,g/ml in batch 2841570, as microbiologically determined [16] Table  3 were seen to be representative for other strains tested, B. fragilis responding to higher concentrations of exogenous thymidine than other common bacteria. DISCUSSION The present study was mainly confined to B. fragilis and some clostridia as the most important anaerobes (11) . As the quite different behavior of P. acnes demonstrates, the results obtained cannot be generalized for all anaerobes.
The inhibition profile established for DHFRs with several different inhibitors shows that large differences exist between all enzymes, including those of E. coli, S. aureus, and rat liver. The differences are statistically significant and often tremendous. Of practical importance is the comparatively low affinity of TMP for many of these enzymes from anaerobes, especially from B. fragilis and clostridia, which require several hundredfold more TMP for I,% than do common pathogens. Diaminoisopropylpteridine and pyrimethamine are as potent as TMP. The figures for pyrimethamine show relatively little variation in the binding to DHFR from various origins, and it may be assumed that pyrimethamine binds to a site which is highly important for function and hence less subject to alteration during evolution than the TMP binding site.
Whereas B. fragilis and clostridia exhibited these relatively TMP-resistant DHFRs, those from other anaerobes such as P. acnes were found to be very susceptible to TMP. The variation among various anaerobes with respect to susceptibility to TMP is therefore quite obvious. In most cases, the differential binding of inhibitors to DHFR is reflected by corresponding in vitro potencies. There are exceptions, however, for TMP at the enzyme and is much more resistant to it in vitro. Because only low levels of dihydrofolate reductase were detected in the C. perfringens strains studied, it seems that TMP, like most of the other compounds, penetrates less well into C. perfringens than into B. fragilis or other anaerobes. C. perfringens 11 (which was originally kept as C. welchii in our collection) and P. acnes proved to be especially susceptible to the diaminopteridine structure in vitro. To some extent, this is also true for B. fragilis, against which the dimethylpteridine is of very low activity at the enzyme, but shows some activity in vitro.
Whereas anaerobes such as P. acnes may be judged to be fully susceptible to co-trimoxazole, the diaminopyrimidine TMP may not be the optimal structure for reductases of B. fragilis and clostridia, which are the most important pathogens in this group (11) . More potent structures may well exist and may be worth looking for.
Some problems arose during the isolation of DHFR from anaerobes. All clostridia and many B. fragilis strains investigated exhibited very low specific activities of DHFR, whereas a high amount of reduced nicotinamide adenine dinucleotide phosphate oxidase, which interferes with the optical assay of DHFR, was present.
Enzyme with a suitable specific activity could be conveniently obtained after the affinity step with a methotrexate affinity column. A column with a relatively low amount of ligand bound to Sepharose (as judged from the faint yellow color) proved superior to columns with a high amount of bound ligand (the gel being brightly yellow), with respect to elution and recovery. Some enzymes proved unstable during the purification procedure but, with the exception of that of C. perfringens 11, dihydrofolate stabilized them sufficiently over the working period.
In vitro, all B. fragilis strains were found to be susceptible to SMZ, whereas the two strains of C. perfringens tested were found to be resistant. TMP was more active against B. fragilis than against the clostridia. Synergism between these two compounds was found in most B. fragilis strains, which were almost exclusively studied in this respect.
As with other TMP-insensitive groups of bacteria, e.g., Neisseria, a higher amount of TMP is needed to get optimal synergism than the usual 20:1 or 10:1 ratio for SMZ/TMP (15) . The optimum found here for B. fragilis was a ratio approaching 1:1. These results are consistent with recent findings of other authors (14, 19) . Because the TMP levels seem higher in many tissues in which anaerobic infections may be located than it does in blood (5), the SMZ/TMP ratio in tissues woulld often be in favor of an optimal in vivo activity against these anaerobes. As yet, however, little is known of the clinical efficacy of co-trimoxazole against infections caused by anaerobes.
It was interesting to see that B. fragilis seems to be less susceptible to the antagonizing effect of exogenous thymidine than are most other bacteria (except Neisseriae). B. fragilis seems, in this respect, to differ from clostridia, which exhibit behavior similar to, e.g., E. coli. Therefore, it seems worthwhile to look for possible differences in either the thymidine kinase content or its properties in B. fragilis. The effect of exogenous thymidine could not, however, be studied very well with most of our clostridia, because the MIC for TMP was already rather high on thymidine-free media.
